Viral Antigens

Creative Biolabs offers a comprehensive suite of viral antigens to empower clients in vaccine research and development. Our viral antigen portfolio encompasses a diverse range of pathogens, including Coxsackie Virus, Crimean-Congo Haemorrhagic Fever Virus, Papillomavirus, Rabies Virus, Respiratory Syncytial Virus, Rotavirus, and many more. These antigens are meticulously validated for high sensitivity and specificity, making them ideal for use as immunogens in vaccine formulations or in serological diagnostic assays. With robust inventory management and global fast-delivery services, we ensure timely access to high-quality materials for urgent projects. Beyond off-the-shelf products, our advanced protein expression systems—featuring E. coli, yeast, baculovirus-insect, and mammalian cell platforms—enable custom production of complex viral antigens, covering gene optimization, vector construction, large-scale purification, and endotoxin removal to meet unique research requirements.

Drive your vaccine project forward with our cutting-edge viral antigen solutions. Whether you need standard catalogue products or fully customized antigen development, our team of experts is dedicated to delivering tailored project plans, detailed milestone reports, and cost-effective strategies, including quantity discounts for bulk orders. Mitigate risks and optimize costs with our small-scale feasibility testing before scaling up to GMP-compliant production. Don’t let technical challenges slow your research—leverage our industry-leading technologies and decades of expertise in antigen production. Contact us today via email or inquiry form to explore how our viral antigens can accelerate your vaccine development and address critical public health needs worldwide.